Abstract
The article describes the results of structural-functional analysis of medicines distribution system in the Ural Federal District (Ural FD). The structure of material flow is heterogeneous in the indicator of logistics channels diversification: the share of trade turnover at federal distributors varies from 17.2 to 100%. There was also an increase in the share of the federal distribution with an increase in the cost of the medication. Methodical approach to risk assessment of pharmaceutical distribution logistics in the Ural FD on the basis of commercial and logistic risk multiplier has been developed and tested. Mathematical modeling of the federal suppliers’ demand for medicines produced in the Urals and the supply of Ural manufacturers with medicines was carried out. Based on the obtained results, methods of reducing the risks of distribution logistics are proposed; in particular, diversification of distribution channels in the range of selling prices of producers excl.VAT from 600 to 800 rubles per package, including by attracting Ural state unitary enterprises with a license for wholesale pharmaceutical activity. In addition, active promotion of expensive medications (more than 700 rubles) is recommended to reduce risks in their distribution and demand increase of federal distributors that will reduce the cost of medications and create additional availability for geriatric use.
Highlights
At the present stage of pharmaceutical logistics development in the Russian Federation, new trends have been identified
The methodical approach basis was formed by the results of situational analysis of the medicines distribution system produced in the Ural Federal District (Ural FD); the structural-functional analysis results of pharmaceutical logistic system of the Ural FD; economic analysis results on pricing in pharmaceutical market wholesale segment; results on organizational and pharmaceutical proposals analysis in the pharmaceutical industry segment of the Ural FD with elements of financial analysis; mathematical modeling results on supply and demand in pharmaceutical market wholesale segment of the Ural FD; results on organizational and pharmaceutical risks analysis of pharmaceutical logistics
To achieve the goal of scientific research, we proposed an algorithm for systemic risk analysis in the distribution logistics of medicines produced in the Ural FD
Summary
At the present stage of pharmaceutical logistics development in the Russian Federation, new trends have been identified. The industry development vector to attract innovative intermediary agents has obviously much to do with the desire of large and medium-sized players to administer their logistical risks [2,3,4,5,6]. In this regard, it is interesting to assess the Ural FD pharmaceutical industry entity inclusion in the structural transformation of the logistics services market. The studies aimed at the development of valid logistic risks assessment methods of medicines manufacturing enterprises localized in the Ural FD are actual within the framework of the medications distribution channels
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
